Jecko Thachil/LinkedIn
Nov 21, 2026, 11:16
Jecko Thachil: Optimizing Corticosteroid Therapy in ITP
Jecko Thachil, Consultant Haematologist at NHS, shared a post on LinkedIn about a recent article he and his colleague co-authored, published in eJHaem, adding:
“Corticosteroids are the first line treatment for immune thrombocytopenia.
But how do we decide on
- Dose
- Tapering
- Pred vs Dex
- Minimising toxicity
All and more detailed here
How We Use Corticosteroids in Immune Thrombocytopenia.”
Title: How We Use Corticosteroids in Immune Thrombocytopenia
Authors: Gerard Gurumurthy, Mervyn Morgan, Drew Provan, Jecko Thachil

Other posts featuring Jecko Thachil on Hemostasis Today.
-
Nov 21, 2026, 08:36Sangwan Sim: ASH 2026 to Highlight Research into PU.1-Related Neutrophil Dysfunction
-
Nov 21, 2026, 08:29Liz Tate: First Percutaneous LAAO Procedure Performed at The Park Hospital for Stroke Prevention
-
Nov 21, 2026, 08:26Robert Sidonio: WFH Webinar to Address Key Challenges in Rare Bleeding Disorders Care
-
Nov 21, 2026, 08:21Jenni Majumdar: What Changing Blood Transfusion Guidelines Mean for Patients and Surgical Teams
-
Nov 21, 2026, 08:17Doaa El Demerdash: The Bridge Meeting Fosters International Dialogue on Hemophilia Care
-
Nov 21, 2026, 08:16Emily Branchard: Uncoupling Anticancer and Antiplatelet Effects of Dipyridamole Analogs
-
Nov 21, 2026, 08:10Rory R Koenen: Xin Xin Earns PhD for Research on Extracellular Vesicles and Vascular Inflammation
-
Nov 21, 2026, 08:06Andrew Hill: How Do You Build Loyalty when Financial Incentives Are off the Table?
-
Nov 21, 2026, 08:00Kevin Dean: How Leptin Receptor Positive Stromal Cells Regulate Platelet Production